Other studies have shown that melatonin enhances cytotoxic effects of chemotherapeutic agents in cancer cells, increasing hepatocellular carcinoma sensitivity to sorafenib via the PERK‐ATF4‐Beclin1 pathway [33, 99]. This evidence concerns the gene BECN1 and cancer.